UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 6-K
__________________
Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934
August 22, 2018
Commission File Number: 001-38283
__________________________________
InflaRx N.V.
__________________________________
Winzerlaer Str. 2
07745 Jena, Germany
(+49) 3641 508180
(Address of principal executive offices)
__________________________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F☒ Form 40-F☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):☐
INFLARX N.V.
On August 22, 2018 InflaRx N.V. convened an extraordinary general meeting of shareholders to be held on September 21, 2018 and made available to its shareholders certain other materials in connection with such meeting.
Such materials are attached as exhibits to this Form 6-K and are incorporated by reference herein.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Jena, Germany, August 22, 2018.
INFLARX N.V. | ||
By: | /s/ Niels Riedemann | |
Name: Niels Riedemann Title: Chief Executive Officer |
EXHIBIT INDEX
Exhibit | Description of Exhibit |
99.1 | Convening notice including agenda and explanatory notes |
99.2 | Voting proxy |